JPWM
GILD icon

Jamison Private Wealth Management’s Gilead Sciences GILD Stock Holding History

Jamison Private Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.15M Buy
32,855
+864
+3% +$114K 0.42% 62
2026
Q1 		$4.46M Buy
31,991
+264
+0.8% +$37K 0.54% 57
2025
Q4 		$3.89M Buy
31,727
+274
+0.9% +$33.3K 0.47% 58
2025
Q3 		$3.49M Buy
31,453
+1,953
+7% +$222K 0.44% 62
2025
Q2 		$3.27M Buy
29,500
+884
+3% +$94.1K 0.47% 58
2025
Q1 		$3.21M Buy
28,616
+659
+2% +$68K 0.49% 55
2024
Q4 		$2.58M Buy
27,957
+1,521
+6% +$137K 0.38% 61
2024
Q3 		$2.22M Buy
26,436
+816
+3% +$62.3K 0.34% 72
2024
Q2 		$1.76M Sell
25,620
-847
-3% -$56.5K 0.29% 76
2024
Q1 		$1.94M Sell
26,467
-1,506
-5% -$116K 0.33% 70
2023
Q4 		$2.27M Buy
27,973
+16
+0.1% +$1.25K 0.42% 62
2023
Q3 		$2.1M Buy
+27,957
New +$2.15M 0.43% 63

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jamison Private Wealth Management's GILD Position: Q2 2026 in Review

Jamison Private Wealth Management increased its Gilead Sciences (GILD) stake by 2.7% in Q2 2026, buying an estimated $114K and bringing the position to 32,855 shares worth $4.15M. The position accounts for 0.42% of the portfolio, ranked #62.

Jamison Private Wealth Management first reported a position in GILD in Q3 2023 and has held it in 12 quarters since. The position peaked at $4.46M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Jamison Private Wealth Management held 32,855 shares of Gilead Sciences worth $4.15M as of Q2 2026.
  • Jamison Private Wealth Management bought 864 Gilead Sciences shares in Q2 2026, an estimated $114K.
  • Gilead Sciences made up 0.42% of Jamison Private Wealth Management's portfolio in Q2 2026, its #62 holding.
  • Jamison Private Wealth Management first reported a position in Gilead Sciences in Q3 2023 and has held it in 12 quarters since.
  • Jamison Private Wealth Management's Gilead Sciences position peaked at $4.46M in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Jamison Private Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.